Skip to main content
. 2018 Aug 20;24(6):836–843. doi: 10.1634/theoncologist.2018-0264

Figure 2.

image

PFS for patients with progressing brain metastases without radiation, progressing brain metastases with radiation, and stable brain disease at the time of starting osimertinib.

Abbreviations: CI, confidence interval; PFS, progression‐free survival.